Vascular endothelial growth factor in allergen-induced nasal inflammation

Clinical and Experimental Allergy

Volumn 39, Issue 5, 2009, Pages 655-661

  Choi, G S ^a   Park, H J ^a   Hur, G Y ^b   Choi, S J ^c   Shin, S Y ^d   Ye, Y M ^a   Park, H S ^a  

^a Ajou University School of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Good Samaritan Hospital   (South Korea)

^d Kyung Hee University Hospital   (South Korea)

Author keywords

Allergic rhinitis; Eosinophil; Nasal provocation; Vascular endothelial growth factor (VEGF)

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; VASCULOTROPIN;

ADULT; ALLERGIC RHINITIS; ALLERGY TEST; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; EOSINOPHIL COUNT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE MUCUS; PRIORITY JOURNAL; PROTEIN SECRETION; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION;

ADULT; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; DERMATOPHAGOIDES PTERONYSSINUS; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; NASAL LAVAGE FLUID; NASAL PROVOCATION TESTS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 64649090866     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2009.03216.x     Document Type: Article

References (34)

1. Bousquet J, Khaltaev N, Cruz AA et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008 63 : 8 160.
2. Rosenwasser L. New insights into the pathophysiology of allergic rhinitis. Allergy Asthma Proc 2007 28 : 10 5.
3. Nouri-Aria KT, O'Brien F, Noble W et al. Cytokine expression during allergen-induced late nasal responses: IL-4 and IL-5 mRNA is expressed early (at 6 h) predominantly by eosinophils. Clin Exp Allergy 2000 30 : 1709 16.
4. Gelfand EW. Inflammatory mediators in allergic rhinitis. J Allergy Clin Immunol 2004 114 : S135 8.
5. Bentley AM, Jacobson MR, Cumberworth V et al. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol 1992 89 : 877 83.
6. Benson M, Reinholdt J, Cardell LO. Allergen-reactive antibodies are found in nasal fluids from patients with birch pollen-induced intermittent allergic rhinitis, but not in healthy controls. Allergy 2003 58 : 386 92.
7. Tomassini M, Tsicopoulos A, Tai PC et al. Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation. J Allergy Clin Immunol 1991 88 : 365 75.
8. Naclerio R, Togias A, Flowers B et al. Nasal lavage: a technique for elucidating the pathophysiology of allergic rhinitis. In : Mygind NPU, Dahl R, eds. Rhinitis and asthma. Copenhagen : Munksgaard, 1990 213 21.
9. Bisgaard H, Robinson C, Romeling F et al. Leukotriene C4 and histamine in early allergic reaction in the nose. Allergy 1988 43 : 219 27.
10. Ferrara N. VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol 2000 11 : 617 24.
11. Wang D, Clement P, Smitz J et al. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure. Int Arch Allergy Immunol 1995 106 : 278 85.
12. Puxeddu I, Ribatti D, Crivellato E et al. Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol 2005 116 : 531 6.
13. Dvorak HF, Brown LF, Detmar M et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995 146 : 1029 39.
14. Feistritzer C, Kaneider NC, Sturn DH et al. Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils. Am J Respir Cell Mol Biol 2004 30 : 729 35.
15. Benson M, Carlsson B, Carlsson LM et al. Increased expression of vascular endothelial growth factor-A in seasonal allergic rhinitis. Cytokine 2002 20 : 268 73.
16. Oh JH, Hur GY, Ye YM et al. Correlation between specific IgA and eosinophil numbers in the lavage fluid of patients with perennial allergic rhinitis. Allergy Asthma Proc 2008 29 : 152 60.
17. Amin K, Rinne J, Haahtela T et al. Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' duration. J Allergy Clin Immunol 2001 107 : 249 57.
18. Andersson M, Rimmer J, Salome C et al. Dual symptomatic and exudative nasal responses are not characteristics of perennial allergic rhinitis. Acta Otolaryngol 2001 121 : 407 13.
19. Togias A, Naclerio RM, Proud D et al. Studies on the allergic and nonallergic nasal inflammation. J Allergy Clin Immunol 1988 81 : 782 90.
20. Simcock DE, Kanabar V, Clarke GW et al. Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. Am J Respir Crit Care Med 2007 176 : 146 53.
21. Lee YC, Lee HK. Vascular endothelial growth factor in patients with acute asthma. J Allergy Clin Immunol 2001 107 : 1106.
22. Lee KS, Min KH, Kim SR et al. Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma. Am J Respir Crit Care Med 2006 174 : 161 70.
23. Boulay ME, Boulet LP. Airway response to low-dose allergen exposure in allergic nonasthmatic and asthmatic subjects: eosinophils, fibronectin, and vascular endothelial growth factor. Chest 2003 123 : 430S.
24. Baluk P, Lee CG, Link H et al. Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways. Am J Pathol 2004 165 : 1071 85.
25. Asai K, Kanazawa H, Kamoi H et al. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy 2003 33 : 595 9.
26. Charan NB, Baile EM, Pare PD. Bronchial vascular congestion and angiogenesis. Eur Respir J 1997 10 : 1173 80.
27. Kanazawa H, Nomura S, Yoshikawa J. Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis. Am J Respir Crit Care Med 2004 169 : 1125 30.
28. Yuksel H, Kose C, Yilmaz O et al. Increased expression of tissue vascular endothelial growth factor and foetal liver kinase-1 receptor in seasonal allergic rhinitis and relevance to asthma component. Clin Exp Allergy 2007 37 : 1183 8.
29. Kirmaz C, Ozbilgin K, Yuksel H et al. Increased expression of angiogenic markers in patients with seasonal allergic rhinitis. Eur Cytokine Netw 2004 15 : 317 22.
30. Lee CG, Link H, Baluk P et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 2004 10 : 1095 103.
31. Lee YC, Kwak YG, Song CH. Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol 2002 168 : 3595 600.
32. Peebles RS Jr., Liu MC, Adkinson NF Jr. et al. Ragweed-specific antibodies in bronchoalveolar lavage fluids and serum before and after segmental lung challenge: IgE and IgA associated with eosinophil degranulation. J Allergy Clin Immunol 1998 101 : 265 73.
33. Reed CE, Bubak M, Dunnette S et al. Ragweed-specific IgA in nasal lavage fluid of ragweed-sensitive allergic rhinitis patients: increase during the pollen season. Int Arch Allergy Appl Immunol 1991 94 : 275 7.
34. Abu-Ghazaleh RI, Fujisawa T, Mestecky J et al. IgA-induced eosinophil degranulation. J Immunol 1989 142 : 2393 400.